ACET
Price:
$0.8905
Market Cap:
$73.38M
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is base...[Read more]
Industry
Biotechnology
IPO Date
2018-01-26
Stock Exchange
NASDAQ
Ticker
ACET
According to Adicet Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.64. This represents a change of -7.78% compared to the average of 11.54 of the last 4 quarters.
The mean historical Current Ratio of Adicet Bio, Inc. over the last ten years is 8.75. The current 10.64 Current Ratio has changed 12.06% with respect to the historical average. Over the past ten years (40 quarters), ACET's Current Ratio was at its highest in in the March 2022 quarter at 27.07. The Current Ratio was at its lowest in in the September 2017 quarter at 0.
Average
8.75
Median
7.59
Minimum
2.33
Maximum
19.16
Discovering the peaks and valleys of Adicet Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 176.40%
Maximum Annual Current Ratio = 19.16
Minimum Annual Increase = -77.47%
Minimum Annual Current Ratio = 2.33
Year | Current Ratio | Change |
---|---|---|
2023 | 8.41 | -36.48% |
2022 | 13.25 | -23.48% |
2021 | 17.31 | 155.76% |
2020 | 6.77 | 56.74% |
2019 | 4.32 | -77.47% |
2018 | 19.16 | 94.44% |
2017 | 9.86 | 176.40% |
2016 | 3.57 | 43.63% |
2015 | 2.48 | 6.47% |
2014 | 2.33 | -3.97% |
The current Current Ratio of Adicet Bio, Inc. (ACET) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
12.99
5-year avg
10.01
10-year avg
8.75
Adicet Bio, Inc.’s Current Ratio is less than Edgewise Therapeutics, Inc. (26.35), less than Talaris Therapeutics, Inc. (40.33), less than Cullinan Oncology, Inc. (24.46), greater than Vor Biopharma Inc. (4.69), greater than Tenaya Therapeutics, Inc. (5.27), less than Bicycle Therapeutics plc (17.13), greater than IGM Biosciences, Inc. (5.22), greater than Monte Rosa Therapeutics, Inc. (6.03), greater than Stoke Therapeutics, Inc. (5.09), greater than Aerovate Therapeutics, Inc. (8.78), less than Acrivon Therapeutics, Inc. Common Stock (12.75), greater than Anebulo Pharmaceuticals, Inc. (3.45), greater than Agios Pharmaceuticals, Inc. (8.99), greater than Homology Medicines, Inc. (4.19), less than Nkarta, Inc. (12.91), greater than Pliant Therapeutics, Inc. (10.26), greater than Alector, Inc. (3.29), greater than Aadi Bioscience, Inc. (4.89), less than Keros Therapeutics, Inc. (19.03),
Company | Current Ratio | Market cap |
---|---|---|
26.35 | $2.82B | |
40.33 | $116.44M | |
24.46 | $706.59M | |
4.69 | $59.68M | |
5.27 | $124.77M | |
17.13 | $1.01B | |
5.22 | $373.44M | |
6.03 | $435.59M | |
5.09 | $603.29M | |
8.78 | $74.35M | |
12.75 | $190.55M | |
3.45 | $35.27M | |
8.99 | $1.95B | |
4.19 | $3.02M | |
12.91 | $163.71M | |
10.26 | $816.96M | |
3.29 | $179.71M | |
4.89 | $73.94M | |
19.03 | $678.30M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adicet Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Adicet Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Adicet Bio, Inc.'s Current Ratio?
How is the Current Ratio calculated for Adicet Bio, Inc. (ACET)?
What is the highest Current Ratio for Adicet Bio, Inc. (ACET)?
What is the 3-year average Current Ratio for Adicet Bio, Inc. (ACET)?
What is the 5-year average Current Ratio for Adicet Bio, Inc. (ACET)?
How does the current Current Ratio for Adicet Bio, Inc. (ACET) compare to its historical average?